Mesothelioma Survival Rates
Researchers at the Department of Medicine – Brigham and Women’s Hospital in Boston, Mass., conducted a 12-year study to test the efficacy of a three-point malignant pleural mesothelioma therapy regimen.
The three-point therapy regimen entails: **extrapleural pneumonectomy** (surgery involving the complete removal of a pleural mesothelioma patient’s affected lung, the pleural lining of the heart and chest, parts or all of the diaphragm, and any cancer visible to the naked eye); **chemotherapy**; and **radiotherapy**.
From 1980 to 1992, the researchers treated 52 specially selected patients between the ages of 33 to 69 – 53 being the median age. The patients had no “medical contraindication” (no reason to withhold treatment that may be harmful to the patient, as opposed to an “indication” – reason to administer treatment) and all the patients had “potentially resectable mesothelioma,” or mesothelioma that could potentially be surgically removed, as detected by computed tomography (CT) and magnetic resonance imaging (MRI).
[https://www.understandmeso.com/2019/01/mesothelioma-survival-rates_6.html](https://www.understandmeso.com/2019/01/mesothelioma-survival-rates_6.html)
0 Response to "Mesothelioma Survival Rates"
Post a Comment